Purchase Short-Term Access

The Predictive Value of the ELISpot-Based Interferon-[ggr ]–Release Assay for Tuberculosis Disease
Anneke C. Hesseling, MD, MSc; Robert P. Gie, MD; Anna M. Mandalakas, MD, MSc
Annals of Internal Medicine 2009;150:428-429. doi:10.7326/0003-4819-150-6-200903170-00023

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.